Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review

Jack R. Cornelius, Duncan B. Clark, Oscar G. Bukstein, Boris Birmaher, Ihsan M Salloum, Sandra A. Brown

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

This paper reviews the results of an acute phase trial and a five-year follow-up study of fluoxetine in adolescents with major depression and a substance use disorder (SUD). This study included a 12-week open label acute phase study of 13 comorbid adolescents, followed by comprehensive assessments conducted 1, 3, and 5 years after entry into an acute phase fluoxetine trial. The results of the acute phase study and of the 1, 3, and 5-year follow-up assessments have already been published in four papers. The current paper was designed to cover the results of the study across the entire 5-year time spectrum of the study, and to summarize the clinical results across that entire time period. The data from this pilot study suggest that the long-term (5-year) clinical course for the Alcohol Dependence, Cannabis Dependence, and academic functioning of comorbid adolescents following acute phase treatment with SSRIs is generally good. However, the long-term clinical course for the Major Depression of that comorbid adolescent population is surprisingly poor.

Original languageEnglish
Pages (from-to)1824-1833
Number of pages10
JournalAddictive Behaviors
Volume30
Issue number9
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Fluoxetine
Substance-Related Disorders
Depression
Cannabis
Labels
Alcohols
Marijuana Abuse
Alcoholism
Population
Therapeutics

Keywords

  • Adolescents
  • Alcohol use disorder
  • Fluoxetine
  • Follow-up
  • Major depression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder : A review. / Cornelius, Jack R.; Clark, Duncan B.; Bukstein, Oscar G.; Birmaher, Boris; Salloum, Ihsan M; Brown, Sandra A.

In: Addictive Behaviors, Vol. 30, No. 9, 01.10.2005, p. 1824-1833.

Research output: Contribution to journalArticle

Cornelius, Jack R. ; Clark, Duncan B. ; Bukstein, Oscar G. ; Birmaher, Boris ; Salloum, Ihsan M ; Brown, Sandra A. / Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder : A review. In: Addictive Behaviors. 2005 ; Vol. 30, No. 9. pp. 1824-1833.
@article{faf9bf97a3df45a9a2dcf8beffd94eba,
title = "Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: A review",
abstract = "This paper reviews the results of an acute phase trial and a five-year follow-up study of fluoxetine in adolescents with major depression and a substance use disorder (SUD). This study included a 12-week open label acute phase study of 13 comorbid adolescents, followed by comprehensive assessments conducted 1, 3, and 5 years after entry into an acute phase fluoxetine trial. The results of the acute phase study and of the 1, 3, and 5-year follow-up assessments have already been published in four papers. The current paper was designed to cover the results of the study across the entire 5-year time spectrum of the study, and to summarize the clinical results across that entire time period. The data from this pilot study suggest that the long-term (5-year) clinical course for the Alcohol Dependence, Cannabis Dependence, and academic functioning of comorbid adolescents following acute phase treatment with SSRIs is generally good. However, the long-term clinical course for the Major Depression of that comorbid adolescent population is surprisingly poor.",
keywords = "Adolescents, Alcohol use disorder, Fluoxetine, Follow-up, Major depression",
author = "Cornelius, {Jack R.} and Clark, {Duncan B.} and Bukstein, {Oscar G.} and Boris Birmaher and Salloum, {Ihsan M} and Brown, {Sandra A.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1016/j.addbeh.2005.07.007",
language = "English",
volume = "30",
pages = "1824--1833",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder

T2 - A review

AU - Cornelius, Jack R.

AU - Clark, Duncan B.

AU - Bukstein, Oscar G.

AU - Birmaher, Boris

AU - Salloum, Ihsan M

AU - Brown, Sandra A.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - This paper reviews the results of an acute phase trial and a five-year follow-up study of fluoxetine in adolescents with major depression and a substance use disorder (SUD). This study included a 12-week open label acute phase study of 13 comorbid adolescents, followed by comprehensive assessments conducted 1, 3, and 5 years after entry into an acute phase fluoxetine trial. The results of the acute phase study and of the 1, 3, and 5-year follow-up assessments have already been published in four papers. The current paper was designed to cover the results of the study across the entire 5-year time spectrum of the study, and to summarize the clinical results across that entire time period. The data from this pilot study suggest that the long-term (5-year) clinical course for the Alcohol Dependence, Cannabis Dependence, and academic functioning of comorbid adolescents following acute phase treatment with SSRIs is generally good. However, the long-term clinical course for the Major Depression of that comorbid adolescent population is surprisingly poor.

AB - This paper reviews the results of an acute phase trial and a five-year follow-up study of fluoxetine in adolescents with major depression and a substance use disorder (SUD). This study included a 12-week open label acute phase study of 13 comorbid adolescents, followed by comprehensive assessments conducted 1, 3, and 5 years after entry into an acute phase fluoxetine trial. The results of the acute phase study and of the 1, 3, and 5-year follow-up assessments have already been published in four papers. The current paper was designed to cover the results of the study across the entire 5-year time spectrum of the study, and to summarize the clinical results across that entire time period. The data from this pilot study suggest that the long-term (5-year) clinical course for the Alcohol Dependence, Cannabis Dependence, and academic functioning of comorbid adolescents following acute phase treatment with SSRIs is generally good. However, the long-term clinical course for the Major Depression of that comorbid adolescent population is surprisingly poor.

KW - Adolescents

KW - Alcohol use disorder

KW - Fluoxetine

KW - Follow-up

KW - Major depression

UR - http://www.scopus.com/inward/record.url?scp=26644469521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26644469521&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2005.07.007

DO - 10.1016/j.addbeh.2005.07.007

M3 - Article

C2 - 16102905

AN - SCOPUS:26644469521

VL - 30

SP - 1824

EP - 1833

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

IS - 9

ER -